Van Cleef Asset Management,Inc Novo Nordisk A S Transaction History

Van Cleef Asset Management,Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $46,550 - $56,270	-500 Reduced 5.78%	8,154 $906,000
Q4 2020 Feb 17, 2021	SELL	$63.89 - $73.8 $14,375 - $16,605	-225 Reduced 2.53%	8,654 $604,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $11,218 - $13,108	-225 Reduced 2.47%	8,879 $514,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $15,369 - $17,482	-370 Reduced 3.91%	9,104 $419,000
Q4 2017 Feb 02, 2018	SELL	$47.53 - $53.73 $9,981 - $11,283	-210 Reduced 2.17%	9,474 $508,000
Q3 2017 Oct 27, 2017	BUY	$41.15 - $49.22 $398,496 - $476,646	9,684	9,684 $466,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

Stay updated on Van Cleef Asset Management,Inc with notifications on news.